Adding simvastatin to escitalopram did not improve depressive symptoms in patients with major depression and obesity. Add-on ...

Finally, sources told WSJ that Witty didn't have a background in the U.S. insurance industry; he was formerly the CEO of ...

The FDA approved darolutamide (Nubeqa) for metastatic castration-sensitive prostate cancer (mCSPC). The agency previously ...

As we brace for hotter summers and more erratic weather patterns nationwide, we must see this pollen surge not as an isolated ...

CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

CHICAGO -- A single infusion of the chimeric antigen receptor (CAR) T-cell therapy ciltacabtagene autoleucel (cilta-cel; ...

Among patients who received four-drug consolidation therapy, 84% had measurable residual disease (MRD)-negative status before ...

Rose Hayes, RN, BSN, MA, is a nurse and a writer who helps scientists and clinicians to share their work with the public. Her ...

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

LOS ANGELES -- For Xavier Becerra, who was the HHS secretary during the Biden administration and now a candidate for ...

Hydrocortisone oral solution (Khindivi) was approved as a replacement therapy for pediatric patients ages 5 years and up with ...

Nearly 5 million Americans with diabetes would qualify to use a GLP-1 receptor agonist for primary stroke prevention but few ...